32nd week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160228498 | METHODS OF PREVENTING OR TREATING MUCOSITIS USING RLIP76 | 2016-08-11 |
20160228499 | THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA | 2016-08-11 |
20160228500 | Immunogenic Polypeptides and Monoclonal Antibodies | 2016-08-11 |
20160228501 | COMPOSITION FOR INHIBITING HUMAN CYTOMEGALOVIRUS REPLICATION | 2016-08-11 |
20160228502 | REGULATING CALCIUM IN EXCITABLE CELLS WITH A NOVEL PROTEIN | 2016-08-11 |
20160228503 | Compositions and Formulations for Prevention and Treatment of Diabetes and Obesity, and Methods of Production and Use Thereof in Glucose and Caloric Control | 2016-08-11 |
20160228504 | S100 BASED TREATMENT OF CARDIAC POWER FAlLURE | 2016-08-11 |
20160228505 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | 2016-08-11 |
20160228506 | Compositions and Formulations for Prevention and Reduction of Tumorigenesis, Cancer Cell Proliferation and Invasion, and Methods of Production and Use Thereof in Cancer Treatment | 2016-08-11 |
20160228507 | ISOLATED MUCINS AND DIFFERENT MICROORGANISMS, AND METHODS OF USE | 2016-08-11 |
20160228508 | CARTILAGE PRODUCT | 2016-08-11 |
20160228509 | Diagnostic BioMarkers for Fibrotic Disorders | 2016-08-11 |
20160228510 | Method of Treating or Improving Neurological Function in a Human Subject | 2016-08-11 |
20160228511 | INHIBITION OF THE TUMORIGENIC POTENTIAL OF TUMOR STEM CELLS BY LIF AND BMPS | 2016-08-11 |
20160228512 | IFN-alpha/beta-Independent Mechanism of Antiviral Protection Through a Novel Ligand-receptor Pair: IFN-lambda Ligands Engage a Novel Receptor IFN-lambdaR1 (CRF2-12) and IL-10R2 (CRF2-4) for Signaling and Induction of Biological Activities | 2016-08-11 |
20160228513 | TREATMENT OF MELANOMA WITH INTERFERON-BETA AND RAS-RAF-MEK-ERK INHIBITOR COMBINATION THERAPY | 2016-08-11 |
20160228514 | USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2016-08-11 |
20160228515 | METHODS TO TREAT DYSREGULATED BLOOD GLUCOSE DISORDERS | 2016-08-11 |
20160228516 | Long-Acting Formulations of Insulin | 2016-08-11 |
20160228517 | High Osteocalcin Microcrystalline Hydroxyapatite For Calcium Supplement | 2016-08-11 |
20160228518 | Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract | 2016-08-11 |
20160228519 | THERAPEUTIC VEGETABLE SUBSTANCES | 2016-08-11 |
20160228520 | Compositions and Methods for Treating Granulomatosis with Polyangiitis | 2016-08-11 |
20160228521 | MANAGING IMMUNE RESPONSES IN TRANSPLANTATION | 2016-08-11 |
20160228522 | Oligomer-Specific Amyloid Beta Epitope and Antibodies | 2016-08-11 |
20160228523 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA | 2016-08-11 |
20160228524 | AUTOLOGOUS CANCER CELL VACCINE | 2016-08-11 |
20160228525 | MALARIA VACCINE | 2016-08-11 |
20160228526 | LPS VACCINE | 2016-08-11 |
20160228527 | YERSINIA SPP. POLYPEPTIDES AND METHODS OF USE | 2016-08-11 |
20160228528 | A SINGLE OR MULTISTAGE MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS SUBUNIT VACCINE | 2016-08-11 |
20160228529 | MENINGOCOCCAL VACCINE FORMULATIONS | 2016-08-11 |
20160228530 | COMBINATION THERAPY FOR USE IN CANCER THERAPY | 2016-08-11 |
20160228531 | TREATMENT OF HEPATITIS D VIRUS INFECTIONS BY REDIRECTION OF T CELLS | 2016-08-11 |
20160228532 | METHOD OF OBTAINING THERMOSTABLE DRIED VACCINE FORMULATIONS | 2016-08-11 |
20160228533 | Use of EGFR Pathway Inhibitors to Increase Immune Responses to Antigens | 2016-08-11 |
20160228534 | INFLUENZA VIRUS MUTANTS AND USES THEREFOR | 2016-08-11 |
20160228535 | INFLUENZA VIRUS MUTANTS AND USES THEREFOR | 2016-08-11 |
20160228536 | RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND VACCINES | 2016-08-11 |
20160228537 | REVERSE VACCINATION THERAPY OF MULTIPLE SCLEROSIS | 2016-08-11 |
20160228538 | Porcine Pseudorabies Virus (PRV)-YF Strain and Its Application | 2016-08-11 |
20160228539 | Toothpaste for Delivery of Allergens to Oral Mucosa | 2016-08-11 |
20160228540 | NASAL MUCOSAL VACCINE COMPOSITION | 2016-08-11 |
20160228541 | PAPAYA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES IN CANCER THERAPY | 2016-08-11 |
20160228542 | METHOD OF INDUCING TOLERANCE TO AN ALLERGEN | 2016-08-11 |
20160228543 | Continuous Cell Programming Devices | 2016-08-11 |
20160228544 | Single Walled Carbon Nanotube Polynucleotide Complexes and Methods Related Thereto | 2016-08-11 |
20160228545 | Methods for treating and/or limiting development of diabetes in subjects with amyotrophic lateral sclerosis | 2016-08-11 |
20160228546 | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF | 2016-08-11 |
20160228547 | CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM | 2016-08-11 |
20160228548 | NANOPARTICLE DELIVERY SYSTEM FOR TARGETED ANTI-OBESITY TREATMENT | 2016-08-11 |
20160228549 | Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same | 2016-08-11 |
20160228550 | COMPOSITIONS AND METHODS OF PROPHYLAXIS FOR CONTACT DERMATITIS | 2016-08-11 |
20160228551 | Method of Treating Disorders using a Pharmaceutical Composition of Oligopeptides | 2016-08-11 |
20160228552 | ORAL COMPOSITION COMPRISING A COOLING AGENT | 2016-08-11 |
20160228553 | Stabilised Solid Compositions of Factor VII Polypeptides | 2016-08-11 |
20160228554 | REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | 2016-08-11 |
20160228555 | REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | 2016-08-11 |
20160228556 | Radiopaque Polymers | 2016-08-11 |
20160228557 | PERSONAL CARE COMPOSITIONS WITH ACID FUNCTIONAL SILICONE BASED STRUCTURING AGENTS | 2016-08-11 |
20160228558 | TRANSDISCAL ADMINISTRATION OF SPECIFIC INHIBITORS OF PRO-INFLAMMATORY CYTOKINES | 2016-08-11 |
20160228559 | COMPOSITION FOR APPLICATION TO A MUCOSA COMPRISING A CELLULOSE ETHER | 2016-08-11 |
20160228560 | INJECTABLE PHARMACEUTICAL COMPOSITIONS FOR SEALING TISSUES | 2016-08-11 |
20160228561 | Protein-Cell Conjugate, Preparation Method and Use Thereof | 2016-08-11 |
20160228562 | MUTUAL PRODRUG COMPRISING SHORT CHAIN FATTY ACIDS AND ZEBULARINE OR 1'-CYANO-CYTARABINE FOR CANCER TREATMENT | 2016-08-11 |
20160228563 | LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE | 2016-08-11 |
20160228564 | Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles | 2016-08-11 |
20160228565 | POLYAMIDE BASED PEPTIDODENDRIMER CONJUGATES | 2016-08-11 |
20160228566 | CARRIER NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | 2016-08-11 |
20160228567 | Hypoxia-Targeted Delivery System for Pharmaceutical Agents | 2016-08-11 |
20160228568 | VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS | 2016-08-11 |
20160228569 | PEPTIDE CONSTRUCTS AND WELL-DEFINED AGGREGATES THEREOF | 2016-08-11 |
20160228570 | Novel Antibody And Use In Diagnosis And Therapy Of Arthropathies | 2016-08-11 |
20160228571 | Anti-DLL3 antibody drug conjugates | 2016-08-11 |
20160228572 | Immobilised Biological Entities | 2016-08-11 |
20160228573 | LIPOSOME ENCAPSULATED AFFINITY DRUG | 2016-08-11 |
20160228574 | PARTICLES WITH MULTIPLE FUNCTIONALIZED SURFACE DOMAINS | 2016-08-11 |
20160228575 | NARINGENIN COMPLEXES AND METHODS OF USE THEREOF | 2016-08-11 |
20160228576 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2016-08-11 |
20160228577 | TRANSGENIC ANIMALS FOR IN VIVO IMAGING | 2016-08-11 |
20160228578 | COATED UP-CONVERSION NANOPARTICLES | 2016-08-11 |
20160228579 | LIPID NANOPARTICLES AND USES THEREOF | 2016-08-11 |
20160228580 | MIXED MICELLES | 2016-08-11 |
20160228581 | MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME | 2016-08-11 |
20160228582 | Pre-Saturation of the Liver and Subsequent Administration of the Contrast Agent | 2016-08-11 |
20160228583 | Process for the Preparation of Gadobenate Dimeglumine Complex in a Solid Form | 2016-08-11 |
20160228584 | 18F -GLUTATHIONE CONJUGATE AS A PET TRACER FOR IMAGING TUMORS OR NEUROLOGICAL DISORDERS THAT OVEREXPRESS L-PGDS ENZYME | 2016-08-11 |
20160228585 | Formulation, Apparatus and Method for Stabilizing Radiopharmaceuticals | 2016-08-11 |
20160228586 | Compounds and Their Use for Preparation of Tau Imaging Agents and Tau Imaging Formulations | 2016-08-11 |
20160228587 | LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER | 2016-08-11 |
20160228588 | ETHER AND ALKYL PHOSPHOLIPID COMPOUNDS FOR TREATING CANCER AND IMAGING AND DETECTION OF CANCER | 2016-08-11 |
20160228589 | METHODS AND COMPOSITIONS FOR IMAGING DISORDERS USING POLYSPECIFIC AGENTS | 2016-08-11 |
20160228590 | System and Method for Disinfecting Medical Waste | 2016-08-11 |
20160228591 | COMBINATION ELECTRONIC DEVICE DOCK AND DISSINFECTOR | 2016-08-11 |
20160228592 | PLASMA VAPOR CHAMBER AND ANTIMICROBIAL APPLICATIONS THEREOF | 2016-08-11 |
20160228593 | PROCESS CHALLENGE DEVICE AND METHODS | 2016-08-11 |
20160228594 | ORGANIC ACID OR WEAK ACID ADDITION TO ALUM TO INHIBIT AMMONIA VOLATILIZATION FROM POULTRY LITTER | 2016-08-11 |
20160228595 | COMPOSITIONS COMPRISING A FUNCTIONAL PERFUME COMPONENT MIXTURE | 2016-08-11 |
20160228596 | RESILIENT ABSORBENT COFORM NONWOVEN WEB | 2016-08-11 |
20160228597 | Oily Compositions | 2016-08-11 |